Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 3 trial of liposomal amphotericin B for empirical treatment of febrile neutropenia with suspected fungal infection
CTR20212526Phase 3Active
- Sponsor
- CSPC Zhongnuo Pharmaceutical
- Start
- Nov 2021
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal amphotericin b in invasive mycoses, sponsored by CSPC Zhongnuo Pharmaceutical. Started Nov 2021; status: active.
02
Drugs
liposomal amphotericin b
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on CTR20212526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212526.